G-CSF (Granulocyte colony-stimulating factor)

DRUG4 trials

Sponsors

M.D. Anderson Cancer Center, Sanofi, MedSIR, First Affiliated Hospital of Zhejiang University

Conditions

Advanced HR+/HER2- Breast CancerAdvanced Triple-Negative Breast CancerBreast CancerGranulocyte Colony-Stimulating Factor (G-CSF) MobilizationLeukemiaProstate Cancer

Phase 2

2-Chlorodeoxyadenosine and Cytarabine in Patients With Idiopathic Hypereosinophilic Syndrome (HES)

CompletedNCT00483067

M.D. Anderson Cancer CenterLeukemia

Start: 1998-03-31End: 2008-07-31Updated: 2012-08-02

Study of Sacituzumab Govitecan With Atropine to Improve Tolerability in Advanced TNBC and HR+/HER2- Breast Cancer

Not yet recruitingNCT07367178

MedSIRAdvanced HR+/HER2- Breast Cancer, Advanced Triple-Negative Breast Cancer, Breast Cancer

Start: 2026-07-01End: 2028-01-01Target: 30Updated: 2026-01-28

Phase 4

Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer

CompletedNCT01649635

SanofiProstate Cancer

Start: 2012-07-31End: 2016-06-30Updated: 2016-07-06

Unknown Phase

CHRONO-MOBILIZE: Chronotherapy of G-CSF for CD34+ Mobilization in Healthy Donors

Not yet recruitingNCT07423728

First Affiliated Hospital of Zhejiang UniversityGranulocyte Colony-Stimulating Factor (G-CSF) Mobilization

Start: 2026-03-01End: 2027-03-30Target: 160Updated: 2026-02-20